151 related articles for article (PubMed ID: 2425532)
1. Present status and future problems of interferon in the treatment of hematological malignancies.
Kimura K
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1677-87. PubMed ID: 2425532
[No Abstract] [Full Text] [Related]
2. Interferon treatment of human neoplasia.
Strander H
Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
[No Abstract] [Full Text] [Related]
3. Interferon: anticancer agent having multifarious activity.
Yabrov AA
Prog Clin Cancer; 1982; 8():99-145. PubMed ID: 6185970
[No Abstract] [Full Text] [Related]
4. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies].
Imamura Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):934-41. PubMed ID: 3694002
[No Abstract] [Full Text] [Related]
5. Clinical and biological activities of interferon and hematological malignancies.
Ozer H
Biotechnol Ther; 1989-1990; 1(2):109-24. PubMed ID: 2485241
[No Abstract] [Full Text] [Related]
6. Biotherapy with interferon in hematologic malignancies.
Roth MS; Foon KA
Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
[No Abstract] [Full Text] [Related]
7. [Interferons: Clinical applications in hematology].
Ben Rhomdhane N; Ben Ahmed M; Zitouni M; Mtimet B
Tunis Med; 1998 Dec; 76(12):427-36. PubMed ID: 10093482
[No Abstract] [Full Text] [Related]
8. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
Wagstaff J; Scarffe JH; Crowther D
Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
[No Abstract] [Full Text] [Related]
9. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2531-6. PubMed ID: 6594973
[TBL] [Abstract][Full Text] [Related]
10. [Interferons in the treatment of hematological diseases].
Jantunen E; Nousiainen T
Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
[No Abstract] [Full Text] [Related]
11. [Chemotherapy of malignant hematological diseases].
SANCHEZ MEDAL L
Gac Med Mex; 1953; 83(6):443-51. PubMed ID: 13151339
[No Abstract] [Full Text] [Related]
12. Biotherapy with interferon--1988.
Figlin RA
Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
[TBL] [Abstract][Full Text] [Related]
13. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effect of interferon on primary malignant tumour cells. Studies in various malignancies.
Grandér D; Xu B; Einhorn S
Eur J Cancer; 1993; 29A(14):1940-3. PubMed ID: 7506559
[TBL] [Abstract][Full Text] [Related]
15. [Interferon (IFN) in multiple myeloma and non-Hodgkin's lymphoma].
Gola A
Acta Haematol Pol; 1994; 25(2 Suppl 1):136-41. PubMed ID: 7520658
[TBL] [Abstract][Full Text] [Related]
16. Interferon therapy in cancer: from imaginon to interferon.
Goldstein D; Laszlo J
Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950
[No Abstract] [Full Text] [Related]
17. Clinical and biological activity of the interferons in hematologic malignancies.
Gutterman JU
Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
[No Abstract] [Full Text] [Related]
18. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hematologic diseases with alpha interferon].
Castaigne S
Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
[TBL] [Abstract][Full Text] [Related]
20. [Interferon therapy in hematologic neoplasms].
Schwarzinger I; Bettelheim P; Lechner K
Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
